Allstate Investment Management CO Novo Cure LTD Transaction History
Allstate Investment Management CO
- $3.29 Billion
- Q4 2022
A detailed history of Allstate Investment Management CO transactions in Novo Cure LTD stock. As of the latest transaction made, Allstate Investment Management CO holds 3,956 shares of NVCR stock, worth $62,227. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,956Holding current value
$62,227% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$191 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$186 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$125 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$67.8 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$47.7 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.65B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...